How Does Glucagon Work: 7 Key Mechanisms of This Peptide Product
Abstract: Glucagon, a 29-amino-acid peptide, counteracts hypoglycemia via seven key mechanisms: hepatic glycogenolysis, gluconeogenesis, lipolysis, ketogenesis, insulin suppression, increased heart rate, and enhanced glucose uptake. The global peptide therapeutics market, valued at $40.5 billion in 2023, is projected to grow at 8.9% CAGR through 2030, driven by diabetes and obesity treatments. Leading brands (Novo Nordisk’s GlucaGen, Eli Lilly’s Baqsimi) differ in stability and delivery (injectable vs. nasal). Peptide products offer high specificity but face short half-lives and cold-chain logistics challenges. Regulatory compliance (FDA, GMP) and purity (>98%) are critical for efficacy. Selection criteria include bioactivity, stability, and manufacturer certifications.